Assembly Biosciences (ASMB) Operating Expenses (2010 - 2026)

Assembly Biosciences' Operating Expenses history runs 17 years deep, the most recent figure standing at $19.6 million for Q1 2026.

• In Q1 2026, Operating Expenses rose 1.15% year-over-year to $19.6 million; the TTM figure through Mar 2026 stood at $84.6 million (up 10.23% YoY), while the FY2025 annual figure was $84.4 million, up 14.18% from the prior year.
• Operating Expenses for Q1 2026 stood at $19.6 million, down from $22.7 million in the prior quarter.
• The five-year high for Operating Expenses was $24.6 million in Q2 2022, with the low at $15.0 million in Q3 2023.
• The 5-year median for Operating Expenses is $19.7 million (2023), against an average of $20.2 million.
• The sharpest annual moves came in 2022 and 2025: Operating Expenses tumbled 63.46% in 2022, then gained 21.75% in 2025.
• Assembly Biosciences' Operating Expenses stood at $23.0 million in 2022, then declined by 14.2% to $19.7 million in 2023, then dropped by 4.18% to $18.9 million in 2024, then gained by 20.02% to $22.7 million in 2025, then decreased by 13.62% to $19.6 million in 2026.
• Business Quant data shows ASMB's Operating Expenses at $19.6 million in Q1 2026, $22.7 million in Q4 2025, and $21.7 million in Q3 2025.